Literature DB >> 11344735

Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever.

G Regev-Yochay1, E Segal, E Rubinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11344735

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  5 in total

1.  Presence of Rickettsia conorii subsp. israelensis, the causative agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retrospective study.

Authors:  Giovanni M Giammanco; Giustina Vitale; Serafino Mansueto; Giuseppina Capra; Maria Pia Caleca; Pietro Ammatuna
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Tick-borne rickettsioses around the world: emerging diseases challenging old concepts.

Authors:  Philippe Parola; Christopher D Paddock; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients.

Authors:  Rita de Sousa; Ana França; Sónia Dória Nòbrega; Adelaide Belo; Mario Amaro; Tiago Abreu; José Poças; Paula Proença; José Vaz; Jorge Torgal; Fátima Bacellar; Nahed Ismail; David H Walker
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

4.  New Real-Time PCRs to Differentiate Rickettsia spp. and Rickettsia conorii.

Authors:  Valeria Blanda; Rosalia D'Agostino; Elisabetta Giudice; Kety Randazzo; Francesco La Russa; Sara Villari; Stefano Vullo; Alessandra Torina
Journal:  Molecules       Date:  2020-09-27       Impact factor: 4.411

5.  Spotted Fever Group Rickettsioses in Israel, 2010-2019.

Authors:  Regev Cohen; Talya Finn; Frida Babushkin; Yael Paran; Ronen Ben Ami; Alaa Atamna; Sharon Reisfeld; Gabriel Weber; Neta Petersiel; Hiba Zayyad; Eyal Leshem; Miriam Weinberger; Yasmin Maor; Nicola Makhoul; Lior Nesher; Galia Zaide; Dar Klein; Adi Beth-Din; Yafit Atiya-Nasagi
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.